Given that knockout of AHR (whole body or Pdgfrα-Cre mediated) can protect against obesity, it is reasonable to propose that this metabolite is an AHR agonist. This evidence concerns the gene PDGFRA and obesity due to melanocortin 4 receptor deficiency.